Rick Mountcastle

Rick Mountcastle was an assistant U.S. attorney whose work in the federal investigation of Purdue Pharma helped transform a sprawling record of OxyContin promotion and misuse into a criminal case. Based in Abingdon, nearer the Virginia coalfields than the district’s main office, he and Randy Ramseyer approached a powerful pharmaceutical company without public theatrics, relying instead on patient document review and experience with drug-related prosecutions.

Identity and Setting

Mountcastle was a career government lawyer, appointed by U.S. Attorney John Brownlee to help lead the investigation of Purdue. He worked with Ramseyer from the district’s satellite office in Abingdon, about three hours west of Brownlee and closer to the Virginia coalfields. The prosecutors were described as restrained rather than dramatic; they did not court the press or carry a podium as a public symbol of the case.

That modest profile contrasted with the scale of their target. The investigation required the prosecutors to contend with a major drug company and high-priced legal representation, while Purdue, according to the book’s account, underestimated the small-town team. Mountcastle’s role is presented less through personal publicity than through the work of the office and the case it assembled.

Building the Case

Mountcastle and Ramseyer had watched their caseloads shift after OxyContin’s introduction. Their office had already prosecuted a series of pill-mill doctors, including a physician who issued prescriptions from the back seat of his car. Since the drug’s arrival, the small Abingdon office had successfully prosecuted ten doctors, pharmacists, and dentists for overprescribing drugs, including prescriptions for children as young as nine. That local experience formed part of the practical background against which they examined Purdue’s conduct.

The federal investigation drew on a much larger documentary effort. Brownlee’s team logged millions of records in spreadsheets, while a dedicated employee catalogued documents. Records from earlier civil litigation, including sales-representative call notes and depositions, were folded into the prosecution’s files. Over five years, nine state and federal agencies helped the prosecutors develop the case. The book describes Mountcastle and Ramseyer as among the stone-faced lawyers who worked through this material, rather than treating the investigation as a public campaign.

The Misbranding Theory

The prosecution’s charge centered on criminal misbranding: the broad, technical offense of mislabeling a drug, promoting it fraudulently, or marketing it for an unapproved use. Unlike the civil cases that came before it, the government did not have to prove that Purdue’s misbranding directly caused particular overdoses, addictions, or instances of misuse. It had to prove the criminal misbranding itself.

That distinction shaped the case’s significance. The legal question was difficult and, as a courts reporter put it, murky; the prosecutors nevertheless worked out how to pursue it. Their task was not to resolve every causal link between the company’s promotion and individual harm, but to establish a charge that could hold up as a federal criminal case. The focused theory made it possible to bring the company’s marketing conduct before a court without having to demonstrate that it caused each injury described in the broader crisis.

Plea and Professional Consequences

At the plea proceedings, Ramseyer argued that Purdue’s corporate officers had not been powerless to prevent the crime and, as officers, had a duty to ensure that misbranding did not occur. He also warned that the company would seek to minimize the crimes to which it had pleaded guilty. These were Ramseyer’s public remarks, not a recorded statement by Mountcastle, but they articulated the prosecutorial position that the two Abingdon lawyers had helped develop.

The account places Mountcastle within a team whose understated manner concealed the persistence and scale of its work: millions of records, years of investigation, and a legal theory built around what the government could prove. It does not supply a separate account of Mountcastle’s private life or later career. His documented significance is his part in a federal prosecution that challenged the assumption that a small regional office could not make a major pharmaceutical company answer in criminal court.